Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Some aspects on the pathophysiology of migraine and a review of device therapies for migraine and cluster headache

Research output: Contribution to journalReviewResearchpeer-review

  1. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment

    Research output: Contribution to journalReviewResearchpeer-review

  2. Postictal inhibition of the somatosensory cortex

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Does inflammation have a role in migraine?

    Research output: Contribution to journalReviewResearchpeer-review

  2. The changing faces of migraine

    Research output: Contribution to journalEditorialResearchpeer-review

  3. CGRP receptor antagonist MK-8825 attenuates cortical spreading depression induced pain behavior

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Board Walk - July 2019

    Research output: Contribution to journalEditorialResearchpeer-review

View graph of relations

Migraine is a common, severe disease, affecting the brain and blood vessels, causing much pain, time missed from work and family, and severe disability. It affects approximately 12% of most Western populations studied and affects women three times more than men. Cluster headache is a much less common dysfunction of the hypothalamus, involving the sphenopalatine ganglion and other areas; it causes more frequent, shorter, and even more intense pain than migraine. The pain usually comes in cycles and is associated with ipsilateral autonomic features and associated with irritability and inability to stay still. It affects less than 0.1% of the population and is slightly more prevalent in men than women. Although we have some acute care and preventive medications for both types of headache, no treatment is optimal for each patient and some will not respond well or have significant adverse events to existing therapies.

Original languageEnglish
JournalNeurological Sciences
Volume40
Issue numberSuppl 1
Pages (from-to)75-80
Number of pages6
ISSN1590-1874
DOIs
Publication statusPublished - May 2019
Externally publishedYes

    Research areas

  • CGRP, Cluster headache therapy, Headache devices, Migraine therapy, Monoclonal antibodies to calcitonin gene–related peptide or its receptor, Pathophysiology of migraine

ID: 57158493